Soligenix
SNGX
#10407
Rank
ยฃ8.77 M
Marketcap
ยฃ0.87
Share price
-2.54%
Change (1 day)
-48.63%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.45. In 2024 the company made an earnings per share (EPS) of -ยฃ3.77 an increase over its 2023 EPS that were of -ยฃ9.58.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-35.45%
2024-ยฃ3.77-60.66%
2023-ยฃ9.58-83.55%
2022-ยฃ58.2313.95%
2021-ยฃ51.10-56.03%
2020-ยฃ116.2233.33%
2019-ยฃ87.16-29.41%
2018-ยฃ123.48-41.38%
2017-ยฃ210.6524.73%
2016-ยฃ168.88-69%
2015-ยฃ544.78-6.25%
2014-ยฃ581.10-50.77%
2013-ยฃ1,18075.68%
2012-ยฃ671.8968.18%
2011-ยฃ399.50-69.86%
2010-ยฃ1,326-8.75%
2009-ยฃ1,45333.33%
2008-ยฃ1,090-57.14%
2007-ยฃ2,542-46.15%
2006-ยฃ4,72144.44%
2005-ยฃ3,269-40.7%
2004-ยฃ5,512-15.62%
2003-ยฃ6,533-25.52%
2002-ยฃ8,772-80.94%
2001-ยฃ46,020160.89%
2000-ยฃ17,639-40.57%
1999-ยฃ29,679-63.84%
1998-ยฃ82,080601.73%
1997-ยฃ11,697101.7%
1996-ยฃ5,799

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.43-443.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.03-141.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.56-163.74%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.72-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.54-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.94-138.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.07-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA